| |
Twelve Thousand New Parkinson Cases Listed Each Year In France
By John Taylor
With 100 000 reached people, Parkinson is the second neurodegenerative disease in France, behind Alzheimer.
At the time of the parliamentary conference organized in Paris on the Parkinson's disease many patients came to discuss with the doctors about all their difficulties but also their hopes regarding the researches which promise to offers solutions to their sufferings. Several doctors pointed out how the arrival of a drug, L-Dope, in the years 1960-1970, metamorphosed the course of the patients by delaying in a spectacular way the appearance of the possible handicaps. In addition, the new techniques of cerebral stimulation currently allow a small number of very handicapped patients - answering very precise criteria - to find a quasi normal life. Like all the affections related to ageing, the Parkinson's disease progresses and concerns currently 100 000 people in France, with 12 000 new cases each year.
The exact causes are hardly known, even if family forms relate to 15% of the patients and that the pesticides represent a supporting factor in certain cases. The beginning of the disease is often insidious and very progressive. This affection is the second neurodegenerative disease in France. If the patients present three types of principal symptoms schematically, a tremor at rest, an akinesy (scarcity and slowness of the gestures) and a rigidity, i.e. a muscular stiffness of the flexors, the reality of the disease is much more complex, with a pallet of symptoms much broader and variable from one person to another.
It was shown that it was a lesion of a quite precise zone of the brain, the Niger locus, which was responsible for the disease by causing the fall of production of a major neuro-transmitter, the dopamine, which intervenes, inter alia, in the displacement control. An American doctor in the 1950s provided the foundations of the current treatment, while giving L-dopamine to rats used in Parkinson experiments and curing them. This work, which was worth the Nobel Prize to him, transformed the forecast of the disease. The first treatment is easy and relieves the patients during several years, specifies. However, other signs appear and the initially simple treatments become very complex then.
As for all the neurodegeneratives diseases of the brain, the patients claim a catch in social contribution that they currently consider insufficient, and wait for the future scientific research that they hope will bring the saving treatments.
John Taylor is a journalist who has written more articles on this issue and published them at Best Free Library Worldwide .
About the Author
John Taylor is a journalist who has written more articles on this issue and published them at Best Free Library Worldwide .
Article Source: http://www.simplysearch4it.com/article/38020.html
| If you wish to add the above article to your website or newsletters then please include the "Article Source: http://www.simplysearch4it.com/article/38020.html" as shown above and make it hyperlinked. |
| Some other articles by John Taylor | |
| |
|
